TITLE:
A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine

CONDITION:
Chronic Hepatitis B

INTERVENTION:
Entecavir

SUMMARY:

      The purpose of this clinical research study is to assess the safety and effectiveness of
      switching to entecavir compared to continued lamivudine in patients with chronic hepatitis
      B.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 16 Years to N/A
Criteria:

        -  Male and female subjects =/> 16 years of age (or minimum age required in a given
             country) with history of HBeAg-positive chronic hepatitis B infection;

          -  Incomplete response to current lamivudine therapy;

          -  HBeAg-positive;

          -  Absence of coinfection with human immunodeficiency virus (HIV), hepatitis C virus
             (HCV), or hepatitis D virus (HDV);

          -  Absence of other forms of liver disease e.g., alcoholic, autoimmune, biliary disease.
      
